Menu Back toBreak Out Sessions 1B: Evolution of Use of BIG Data on EU Decision Making

Clinical Trials and Data Science Conference


Break Out Sessions 1B: Evolution of Use of BIG Data on EU Decision Making

Session Chair(s)

Álmath Máire Spooner, PhD, RPh

Álmath Máire Spooner, PhD, RPh

  • Director of Regulatory Policy and Intelligence
  • AbbVie, Ireland
Evolution of Use of BIG Data on EU Decision Making

Speaker(s)

Xavier  Kurz, MD, PhD, MSc

BIG Data Workplan - Update: How Can DARWIN-EU Contribute Towards a Digital Future

Xavier Kurz, MD, PhD, MSc

  • Head of Data Analytics Workstream
  • European Medicines Agency, Netherlands
Pall  Jonsson, PhD, MS

HTA perspective on use cases for RWE

Pall Jonsson, PhD, MS

  • Programme Director - Data and RWE
  • National Institute for Health and Care Excellence (NICE), United Kingdom
Patrice  Verpillat, DrMed, MD, PhD, MPH

Use of Big Data and/or RWE in drug development and regulatory submissions

Patrice Verpillat, DrMed, MD, PhD, MPH

  • Head of Global Epidemiology
  • Merck Healthcare KGaA, Germany
Elizabeth  Vroom

Panel discussion with Q&A, with additional participation of:

Elizabeth Vroom

  • President
  • Duchenne Parent Project, Netherlands
Jesper  Kjær, MS

Panel discussion with Q&A, with additional participation of:

Jesper Kjær, MS

  • Co-Chair, EMA/HMA Big Data Steering Group; Director of Data Analytics Centre
  • Danish Medicines Agency (DKMA), Denmark

Contact us

Registration Questions?

Send Email
+41 61 225 51 51